Roderick Baltzer
Family Medicine · Cheboygan, MINPI 1760564041
Payments from drug & device makers
Across 261 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$754
- AbbVie$327
- Boehringer Ingelheim$317
- Pfizer$278
- Amgen$234
- plus $1K from 26 others
What the payments were for
- Food & beverage$5,63899%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 67 | $2,389 |
| Novo Nordisk | 41 | $754 |
| AbbVie(2 entities) | 17 | $327 |
| Boehringer Ingelheim | 15 | $317 |
| Pfizer | 21 | $278 |
| Amgen | 16 | $234 |
| Novartis | 15 | $184 |
| Exact Sciences | 6 | $145 |
| Lilly USA, LLC | 9 | $143 |
| Merck | 7 | $128 |
| Astellas Pharma US Inc | 6 | $107 |
| Sunovion Pharmaceuticals Inc. | 10 | $85 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Johnson & Johnson(2 entities) | 4 | $59 |
| GSK | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Tersera Therapeutics LLC | 1 | $37 |
| AVEO Pharmaceuticals, Inc. | 2 | $33 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Geron Corporation | 1 | $26 |
| Eisai Inc. | 1 | $25 |
| Bioventus LLC | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Corcept Therapeutics | 1 | $21 |
| EMD Serono, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Abiomed | 1 | $18 |
| Sobi, Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,671 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $94,375 |
| OzempicSemaglutide | 54 | $93,258 |
| FarxigaDapagliflozin Propanediol | 74 | $82,565 |
| JardianceEmpagliflozin | 51 | $67,910 |
| XareltoRivaroxaban | 40 | $41,478 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $36,192 |
| RybelsusSemaglutide | 26 | $35,999 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $14,685 |
| Bydureon BciseExenatide Microspheres | 17 | $13,240 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $12,657 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,504 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $7,499 |
| CreonLipase/Protease/Amylase | 12 | $6,359 |
| Atorvastatin Calcium | 423 | $6,155 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $6,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $754 | $129,25780 claims |
| PfizerEliquis | $278 | $94,37579 claims |
| AstraZenecaFarxiga | $2,389 | $82,56574 claims |
| Boehringer IngelheimJardiance | $317 | $67,91051 claims |
| Johnson & JohnsonXarelto | $59 | $41,47840 claims |
| MerckJanumet | $128 | $36,19232 claims |
| GSKTrelegy Ellipta | $55 | $8,50414 claims |
| AbbVieCreon | $327 | $6,35912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Cheboygan
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.